COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic to Host Third Quarter 2018 Results Conference Call
02/11/2018
COPENHAGEN, Denmark - November 2, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 third quarter results on Friday, November 9, 2018. The management of Bavarian Nordic will host a conference [...]
Trading in Novo Nordisk shares by board members, executives and associated persons
02/11/2018
Bagsværd, Denmark, 2 November 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Protech Home Medical Announces Closing of $3.4 Million Bought Deal Offering & $1.1 Million Insider Non-Brokered Offering
02/11/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, Ohio, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ PHM ” or the “ Company ”) (TSXV: PHM [...]
LIDDS: Valberedning inför årsstämman 2019 utsedd
02/11/2018
Vid årsstämman i LIDDS AB (publ) den 16 maj 2018 beslutades att en valberedning skall utses och bestå av tre ledamöter, utsedda av de två största aktieägarna per den 30 september 2018, jämte styrelsens ordförande. [...]
Correction to the Invitation to the Extraordinary General Meeting of Nexstim Plc
02/11/2018
Company announcement, Helsinki, 2 November 2018 at 4:00 PM Correction to the Invitation to the Extraordinary General Meeting of Nexstim Plc Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company [...]
Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
02/11/2018
Investigator-led study has commenced dosing Immunotherapy candidate CV301 is now being assessed in three clinical trials in combination with checkpoint inhibitors in multiple solid tumors COPENHAGEN, Denmark, November 2 [...]
Managers’ transactions
02/11/2018
Company Announcement No. 20/2018 November 2, 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 [...]
Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director
02/11/2018
SYDNEY, Australia and MINNEAPOLIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company )(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the appointment of David B. Kaysen as [...]
United Health Products Retains Legal Counsel Ruskin Moscou Faltischek P.C to Assist in Strategic Review
02/11/2018
HENDERSON, Nev., Nov. 02, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
Long-Awaited Planet 13 Vegas Superstore Opens November 1, 2018 -- CFN Media
02/11/2018
SEATTLE, Nov. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Global Kinetics Corporation’s PKG® Smartwatch Provides Clinically Meaningful Improvement in Parkinson’s Disease Symptom Assessment, Management and Medication Optimization, As Well As Per Projected Patient Cost Savings
02/11/2018
Data Recently Presented at the 2018 International Congress of Parkinson’s Disease and Movement Disorders PORTSMOUTH, N.H., LONDON and MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Global Kinetics Pty Ltd. (GKC [...]
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
02/11/2018
DENVER, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has completed the last [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentations
02/11/2018
COPENHAGEN, Denmark, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technology to address significant unmet medical needs, today [...]
Latin America: The Next Cannabis Frontier -- CFN Media
02/11/2018
SEATTLE, Nov. 02, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Medibio Market Update
02/11/2018
SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent [...]
Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018
02/11/2018
BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare Conference. The Conference is [...]
Results of Cynata’s World-First GvHD Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
02/11/2018
MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that results from Cohort A [...]
Terra Tech Corp. to Report Third Quarter 2018 Earnings on Thursday, November 8, 2018
02/11/2018
IRVINE, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]
Sarepta Therapeutics to Present at Credit Suisse 27th Annual Healthcare Conference
02/11/2018
CAMBRIDGE, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leader in precision genetic medicine for rare diseases, today announced that management will present at the Credit Suisse [...]

Pages